1. Home
  2. PRPH vs CPIX Comparison

PRPH vs CPIX Comparison

Compare PRPH & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • CPIX
  • Stock Information
  • Founded
  • PRPH 1989
  • CPIX 1999
  • Country
  • PRPH United States
  • CPIX United States
  • Employees
  • PRPH N/A
  • CPIX N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPH Health Care
  • CPIX Health Care
  • Exchange
  • PRPH Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • PRPH 15.5M
  • CPIX 17.2M
  • IPO Year
  • PRPH 1997
  • CPIX 2009
  • Fundamental
  • Price
  • PRPH $0.70
  • CPIX $2.36
  • Analyst Decision
  • PRPH Strong Buy
  • CPIX
  • Analyst Count
  • PRPH 1
  • CPIX 0
  • Target Price
  • PRPH $11.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • PRPH 232.3K
  • CPIX 5.5M
  • Earning Date
  • PRPH 11-13-2024
  • CPIX 11-07-2024
  • Dividend Yield
  • PRPH N/A
  • CPIX N/A
  • EPS Growth
  • PRPH N/A
  • CPIX N/A
  • EPS
  • PRPH N/A
  • CPIX N/A
  • Revenue
  • PRPH $12,753,000.00
  • CPIX $36,785,442.00
  • Revenue This Year
  • PRPH $36.93
  • CPIX N/A
  • Revenue Next Year
  • PRPH $132.05
  • CPIX N/A
  • P/E Ratio
  • PRPH N/A
  • CPIX N/A
  • Revenue Growth
  • PRPH N/A
  • CPIX N/A
  • 52 Week Low
  • PRPH $0.64
  • CPIX $1.04
  • 52 Week High
  • PRPH $7.48
  • CPIX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 28.79
  • CPIX 66.16
  • Support Level
  • PRPH $0.66
  • CPIX $2.07
  • Resistance Level
  • PRPH $0.74
  • CPIX $2.93
  • Average True Range (ATR)
  • PRPH 0.06
  • CPIX 0.26
  • MACD
  • PRPH 0.05
  • CPIX 0.08
  • Stochastic Oscillator
  • PRPH 34.44
  • CPIX 53.06

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: